Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Clover Health Investments ( (CLOV) ) has shared an update.
On August 11, 2025, Clover Health Investments, Corp. addressed shareholder inquiries by publishing responses to frequently asked questions prior to its second quarter 2025 earnings announcement. The responses, which include insights from Co-Founder and Executive Chairman Vivek Garipalli, aim to enhance engagement with shareholders and are accessible on the company’s website.
The most recent analyst rating on (CLOV) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on Clover Health Investments stock, see the CLOV Stock Forecast page.
Spark’s Take on CLOV Stock
According to Spark, TipRanks’ AI Analyst, CLOV is a Neutral.
Clover Health’s stock score is influenced by its ongoing financial challenges, despite positive developments in operational metrics and an encouraging earnings call. The financial performance remains a significant concern due to negative margins and revenue decline. Technical indicators signal potential weakness, while valuation remains unattractive due to losses. The company’s achievements in profitability and membership growth offer potential for future improvement.
To see Spark’s full report on CLOV stock, click here.
More about Clover Health Investments
Average Trading Volume: 9,311,716
Technical Sentiment Signal: Sell
Current Market Cap: $1.11B
See more data about CLOV stock on TipRanks’ Stock Analysis page.